Thalidomide in the treatment of neuro-Behçet's syndrome.
No relapses of symptoms in a patient with neuro-Behçet's syndrome were observed after the addition of thalidomide to chlorambucil and prednisolone therapy. At present, the patient has been free of symptoms for 3 years. This observation, together with those reported from the literature, strongly support a re-evaluation of thalidomide therapy in certain life-threatening diseases such as neuro-Behçet's syndrome.
D000328:Adult; D001528:Behcet Syndrome / Q000188:drug therapy*; D002699:Chlorambucil / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009422:Nervous System Diseases / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D013792:Thalidomide / Q000627:therapeutic use*
D002699:Chlorambucil; D013792:Thalidomide; D011241:Prednisone